ARTICLE | Company News
Pfenex, Merck deal
December 21, 2009 8:00 AM UTC
Pfenex granted Merck exclusive, worldwide rights to use Pfenex Expression Technology for the production of proteins to be used in an undisclosed vaccine candidate. The companies will collaborate on de...